Status:
UNKNOWN
Effect of Nutritional Supplementation and Pulmonary Rehabilitation on the Clinical Status of HF and COPD
Lead Sponsor:
Instituto Nacional de Enfermedades Respiratorias
Conditions:
Heart Failure
Copd
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Cardiovascular diseases (CVD) are the leading cause of death in the world and our country. The prevalence of Heart Failure (HF) is 1-2% in the adult population in developed countries, up to 10% among ...
Detailed Description
Heart Failure Heart Failure (HF) is a complex syndrome consequence of any structural or functional abnormality that impairs the capacity of filling or ejected of the heart. (1, 2). Chronic obstructi...
Eligibility Criteria
Inclusion
- Patients that accept and signed the study consent.
- \> 40 years old
- Patients with Heart failure diagnosis confirmed by echocardiographic criteria according to the European Society of Cardiology guidelines (2).
- Heart failure patients in functional class I to III according to NYHA
- Patients with Chronic Obstructive Pulmonary Disease diagnosis according to GOLD guidelines with a post-bronchodilator spirometry VEF1/FVC index \<0.70 (50)
Exclusion
- Patients with recent (\<3 months) exacerbations
- Terminal Chronic Renal Kidney Disease with a creatinine clearance \<30 ml/min/1.73m2
- Patients with a cancer diagnosis
- Patients with limitation to exercise
- Patients enrolled in another study protocol
Key Trial Info
Start Date :
August 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04432194
Start Date
August 30 2019
End Date
September 1 2023
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dulce González-Islas
Mexico City, Mexico City, Mexico, 14080